UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

HIV-1 Vaccines Based on Antibody Identification, B Cell Ontogeny, and Epitope Structure

Immunity (Cambridge, Mass.), 2018-05, Vol.48 (5), p.855-871

2018

Link zum Volltext

Verfügbarkeit prüfen

Human Antibodies that Neutralize HIV-1: Identification, Structures, and B Cell Ontogenies

Immunity (Cambridge, Mass.), 2012-09, Vol.37 (3), p.412-425

2012

Link zum Volltext

Verfügbarkeit prüfen

A strategic approach to COVID-19 vaccine R&D

Science (American Association for the Advancement of Science), 2020-05, Vol.368 (6494), p.948-950

2020

Link zum Volltext

Verfügbarkeit prüfen

HIV-1 neutralizing antibodies: understanding nature's pathways

Immunological reviews, 2013-07, Vol.254 (1), p.225-244

2013

Link zum Volltext

Verfügbarkeit prüfen

Broadly neutralizing antibodies and the search for an HIV-1 vaccine: the end of the beginning

Nature reviews. Immunology, 2013-09, Vol.13 (9), p.693

2013

Link zum Volltext

Verfügbarkeit prüfen

Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7

Nature (London), 2021-05, Vol.593 (7857), p.130-135

2021

Link zum Volltext

Verfügbarkeit prüfen

The role of antibodies in HIV vaccines

Annual review of immunology, 2010-01, Vol.28 (1), p.413-444

2010

Link zum Volltext

Verfügbarkeit prüfen

Rational Design of an Epstein-Barr Virus Vaccine Targeting the Receptor-Binding Site

Cell, 2015-08, Vol.162 (5), p.1090-1100

2015

Link zum Volltext

Verfügbarkeit prüfen

Use of broadly neutralizing antibodies for HIV‐1 prevention

Immunological reviews, 2017-01, Vol.275 (1), p.296-312

2017

Link zum Volltext

Verfügbarkeit prüfen

Broadly Neutralizing Activity of Zika Virus-Immune Sera Identifies a Single Viral Serotype

Cell reports (Cambridge), 2016-08, Vol.16 (6), p.1485-1491

2016

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of broadly neutralizing antibody responses during chronic HIV-1 infection

AIDS (London), 2014-01, Vol.28 (2), p.163-169

2014

Link zum Volltext

Verfügbarkeit prüfen

Potential of conventional & bispecific broadly neutralizing antibodies for prevention of HIV-1 subtype A, C & D infections

PLoS pathogens, 2018-03, Vol.14 (3), p.e1006860-e1006860

2018

Link zum Volltext

Verfügbarkeit prüfen

A single injection of anti-HIV-1 antibodies protects against repeated SHIV challenges

Nature (London), 2016-05, Vol.533 (7601), p.105-109

2016

Link zum Volltext

Verfügbarkeit prüfen

Structural basis for potent antibody neutralization of SARS-CoV-2 variants including B.1.1.529

Science (American Association for the Advancement of Science), 2022-04, Vol.376 (6591), p.eabn8897-eabn8897

2022

Link zum Volltext

Verfügbarkeit prüfen

Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody

Science (American Association for the Advancement of Science), 2016-03, Vol.351 (6279), p.1339-1342

2016

Link zum Volltext

Verfügbarkeit prüfen

Real-Time Conformational Dynamics of SARS-CoV-2 Spikes on Virus Particles

Cell host & microbe, 2020-12, Vol.28 (6), p.880-891.e8

2020

Link zum Volltext

Verfügbarkeit prüfen

Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1

Journal of immunological methods, 2014-07, Vol.409, p.131-146

2014

Link zum Volltext

Verfügbarkeit prüfen

Enhanced neonatal Fc receptor function improves protection against primate SHIV infection

Nature (London), 2014-10, Vol.514 (7524), p.642-645

2014

Link zum Volltext

Verfügbarkeit prüfen

Broad and potent neutralization of HIV―1 by a gp41―specific human antibody

Nature (London), 2012-11, Vol.491 (7424), p.406-412

2012

Link zum Volltext

Verfügbarkeit prüfen

Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01

Science (American Association for the Advancement of Science), 2010-08, Vol.329 (5993), p.811-817

2010

Link zum Volltext

Verfügbarkeit prüfen

Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1

Science (American Association for the Advancement of Science), 2010-08, Vol.329 (5993), p.856-861

2010

Link zum Volltext

Verfügbarkeit prüfen

Optimal Combinations of Broadly Neutralizing Antibodies for Prevention and Treatment of HIV-1 Clade C Infection

PLoS pathogens, 2016-03, Vol.12 (3), p.e1005520-e1005520

2016

Link zum Volltext

Verfügbarkeit prüfen

Passive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaques

The Journal of experimental medicine, 2014-09, Vol.211 (10), p.2061-2074

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 654

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(638)
Mit Volltextzugriff
(572)

Publikationsform

Sprache

Englisch
(654)
Japanisch
(134)

Erscheinungsjahr

n.n

Thema

Science & Technology
(511)
Life Sciences & Biomedicine
(416)
Humans
(387)
Hiv-1 - Immunology
(248)
Animals
(217)
Immunology
(193)
Virology
(190)
Antibodies, Neutralizing - Immunology
(176)
Hiv
(171)
Vaccines
(171)
Human Immunodeficiency Virus
(168)
Hiv Antibodies - Immunology
(161)
Microbiology
(155)
Antibodies
(146)
Infectious Diseases
(145)
Hiv Infections - Immunology
(137)
Female
(118)
Aids Vaccines - Immunology
(113)
Human Immunodeficiency Virus 1
(111)
Biological And Medical Sciences
(108)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

HIV-1 Vaccines Based on Antibody Identification, B Cell Ontogeny, and Epitope Structure

Human Antibodies that Neutralize HIV-1: Identification, Structures, and B Cell Ontogenies

A strategic approach to COVID-19 vaccine R&D

HIV-1 neutralizing antibodies: understanding nature's pathways

Broadly neutralizing antibodies and the search for an HIV-1 vaccine: the end of the beginning

Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7

The role of antibodies in HIV vaccines

Rational Design of an Epstein-Barr Virus Vaccine Targeting the Receptor-Binding Site

Use of broadly neutralizing antibodies for HIV‐1 prevention

Broadly Neutralizing Activity of Zika Virus-Immune Sera Identifies a Single Viral Serotype

Prevalence of broadly neutralizing antibody responses during chronic HIV-1 infection

Potential of conventional & bispecific broadly neutralizing antibodies for prevention of HIV-1 subtype A, C & D infections

A single injection of anti-HIV-1 antibodies protects against repeated SHIV challenges

Cooperation of B Cell Lineages in Induction of HIV-1-Broadly Neutralizing Antibodies

Structural basis for potent antibody neutralization of SARS-CoV-2 variants including B.1.1.529

Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody

Real-Time Conformational Dynamics of SARS-CoV-2 Spikes on Virus Particles

Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1

Enhanced neonatal Fc receptor function improves protection against primate SHIV infection

Broad and potent neutralization of HIV―1 by a gp41―specific human antibody

Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01

Identification of a CD4-Binding-Site Antibody to HIV that Evolved Near-Pan Neutralization Breadth

Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1

Optimal Combinations of Broadly Neutralizing Antibodies for Prevention and Treatment of HIV-1 Clade C Infection

Passive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaques

Suchergebnisse filtern